drugset
drugset / Trial / NCT01001091

AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation

NCT01001091 ↗

Phase 2 Completed 312 enrolled Alcon Research Ophthalmic Research Associates, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the safety and efficacy of AL-38583 in the treatment of the signs of inflammation associated with allergic conjunctivitis.

Timeline

Start
2009-12
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject AL-38583 Unknown 0.01 % Other
Subject AL-38583 Unknown 0.05 % Other
Subject AL-38583 Unknown 0.2 % Other
Comparator Dexamethasone Small molecule 0.1 % Other

Indications

conjunctivitis